Fractyl Health

Fractyl Health is a metabolic therapeutics company focused on the treatment of metabolic diseases, including T2D and obesity.

Inside the small intestine
MedTech

Fractyl pivots T2D therapy to obesity & GLP-1s, lays off staff

The company will instead pitch its outpatient procedure as an “off-ramp” for people looking to stop taking GLP-1s and maintain their weight loss.
Conor Hale Jan 31, 2025 11:45am
Long haired red satin mouse on scales

Fractyl's GLP-1 gene therapy makes weight loss last in mice

Jun 24, 2024 11:11am
Wall Street IPO initial public offering markets shares stock

Alto, Fractyl head to public markets with IPOs north of $100M

Feb 2, 2024 8:14am
Photo of Wall Street street sign with american flags in the background

Alto aims for $101M IPO to pave neuro development climb

Jan 30, 2024 11:37am
IPO initial public offering Wall Street

Fractyl sets out $99M IPO ambitions after busy week for biotechs

Jan 29, 2024 9:31am
Wall Street stock exchange finance shares share price Nasdaq

Hoping its GLP-1 gene therapy can beat Wegovy, Fractyl plans IPO

Dec 15, 2023 5:09am